Evidence map›Paper›PMID 38627044›Full record

ArticleBMJ case reports2024

Breast cryoablation for the palliative treatment of indolent subtype of multicentric triple-negative breast cancer.

Monica L Huang, Deanna L Lane, Hannah Bomar, Henry Kuerer

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMJ case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Monica L HuangBreast Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA mlhuang@mdanderson.org.ORCID http://orcid.org/0000-0002-4665-0274
Deanna L LaneBreast Imaging, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Hannah BomarBreast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Henry KuererBreast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
The University of Texas MD Anderson Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cryoablation for palliative and curative treatment of breast cancer has been performed for decades. Although there is a recent resurgence of interest in breast cryoablation with curative intent for unifocal, hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, this report highlights the essential role that cryoablation can play in the palliative treatment of multicentric oestrogen and progesterone receptor-negative and human epidermal growth factor receptor 2-negative (triple-negative) breast cancer, meeting the select pretreatment objectives such as breast or nipple pain relief and prevention of tumour erosion through the skin or nipple in patients who have failed or cannot tolerate the standard of care treatment.

Indexed as

Breast NeoplasmsCryosurgeryTriple Negative Breast NeoplasmsErb-b2 Receptor Tyrosine KinasesEstrogensFemaleHumansPain ManagementPalliative CareReceptors, ProgesteroneErb-b2 Receptor Tyrosine KinasesEstrogensReceptors, ProgesteroneBreast cancerCancer interventionInterventional radiologyRadiology

Identifiers

PMID38627044
PMCPMC11029424
OpenAlexW4394859254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.